Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients: Relevance for circulating tumor cell detection

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Wang, Lili ^a   Wang, Yanyan ^a   Liu, Yajing ^a   Cheng, Min ^a   Wu, Xu ^a   Wei, Haiming ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKERATIN 19;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLOOD; BLOOD SAMPLING; BREAST CANCER; BREAST CARCINOMA; BREAST TUMOR; CANCER CHEMOTHERAPY; CANCER PATIENT; CELL COUNT; CELL STRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKOCYTE; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; STAINING; CANCER STAGING; DRUG EFFECT; INDICATOR DILUTION CURVE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE; TUMOR EMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; FLOW CYTOMETRY; HUMANS; INDICATOR DILUTION TECHNIQUES; KERATIN-19; MIDDLE AGED; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; SENSITIVITY AND SPECIFICITY;

EID: 66249121076     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-57     Document Type: Article

References (28)

1. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. HL Howe PA Wingo MJ Thun LA Ries HM Rosenberg EG Feigal BK Edwards, J Natl Cancer Inst 2001 93 824 842 10.1093/jnci/93.11.824 11390532 (Pubitemid 32586611)
2. Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer. G Wiedswang E Borgen C Schirmer R Karesen G Kvalheim JM Nesland B Naume, Int J Cancer 2006 118 2013 2019 10.1002/ijc.21576 16287086
3. Central nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/neu status. J Souglakos L Vamvakas S Apostolaki M Perraki Z Saridaki I Kazakou A Pallis C Kouroussis N Androulakis K Kalbakis G Millaki D Mavroudis V Georgoulias, Breast Cancer Res 2006 8 R36 16846533 10.1186/bcr1516
4. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. A Stathopoulou I Vlachonikolis D Mavroudis M Perraki C Kouroussis S Apostolaki N Malamos S Kakolyris A Kotsakis N Xenidis D Reppa V Georgoulias, J Clin Oncol 2002 20 3404 3412 10.1200/JCO.2002.08.135 12177100
5. Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients. TA Masuda A Kataoka S Ohno S Murakami K Mimori T Utsunomiya H Inoue S Tsutsui J Kinoshita N Masuda N Moriyama M Mori, Int J Oncol 2005 26 721 730 15703829
6. The melanoma antigen gene as a surveillance marker for the detection of circulating tumor cells in patients with breast carcinoma. S Kwon SH Kang J Ro CH Jeon JW Park ES Lee, Cancer 2005 104 251 256 10.1002/cncr.21162 15937912
7. Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer. IH Benoy H Elst I Van der Auwera S Van Laere P van Dam E Van Marck S Scharpe PB Vermeulen LY Dirix, Br J Cancer 2004 91 1813 1820 10.1038/sj.bjc.6602189 15505629
8. Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer. DF Hayes TM Walker B Singh ES Vitetta JW Uhr S Gross C Rao GV Doyle LW Terstappen, Int J Oncol 2002 21 1111 1117 12370762
9. The clinical significance of circulating tumour cells in breast cancer and colorectal cancer patients. S Hauch S Zimmermann S Lankiewicz V Zieglschmid O Bocher WH Albert, Anticancer Res 2007 27 1337 1341 17593628 (Pubitemid 46807280)
10. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. M Cristofanilli DF Hayes GT Budd MJ Ellis A Stopeck JM Reuben GV Doyle J Matera WJ Allard MC Miller HA Fritsche GN Hortobagyi LW Terstappen, J Clin Oncol 2005 23 1420 1430 10.1200/JCO.2005.08.140 15735118
11. Fluctuation of circulating tumor cells in patients with lung cancer by real-time fluorescent quantitative-PCR approach before and after radiotherapy. M Ge D Shi Q Wu M Wang L Li, J Cancer Res Ther 2005 1 221 226 17998657
12. Increased levels of CK19 mRNA in oral squamous cell carcinoma tissue detected by relative quantification with real-time polymerase chain reaction. LP Zhong SF Zhao GF Chen FY Ping ZF Xu JA Hu, Arch Oral Biol 2006 51 1112 1119 10.1016/j.archoralbio.2006.05.005 16806049
13. Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer. N Xenidis V Markos S Apostolaki M Perraki A Pallis G Sfakiotaki D Papadatos-Pastos L Kalmanti M Kafousi E Stathopoulos S Kakolyris D Mavroudis V Georgoulias, Ann Oncol 2007 18 1623 1631 10.1093/annonc/mdm208 17515404
14. The value of bone marrow aspirates culture for the detection of bone marrow micrometastasis in breast cancer. WT Loo JH Fong L Zhu MN Cheung LW Chow, Biomed Pharmacother 2005 59 Suppl 2 S384 386 10.1016/S0753-3322(05)80084-8 16507415
15. Immunocytochemical detection of epithelial cells in the bone marrow of primary breast cancer patients: a meta-analysis. P Weinschenker HP Soares O Clark A Del Giglio, Breast Cancer Res Treat 2004 87 215 224 10.1007/s10549-004- 8691-1 15528964
16. Clinical significance of bone marrow micrometastasis detected by nested rt-PCR for keratin-19 in breast cancer patients. YS Jung KJ Lee HJ Kim HE Yim JS Park EY Soh MW Kim HB Park, Jpn J Clin Oncol 2003 33 167 172 10.1093/jjco/hyg038 12810830
17. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay. A Fabisiewicz J Kulik P Kober E Brewczynska T Pienkowski JA Siedlecki, Acta Biochim Pol 2004 51 747 755 15448736 (Pubitemid 39296928)
18. Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients. JY Pierga C Bonneton A Vincent-Salomon P de Cremoux C Nos N Blin P Pouillart JP Thiery H Magdelenat, Clin Cancer Res 2004 10 1392 1400 10.1158/1078-0432.CCR-0102-03 14977842
19. Identification of carcinoma cells in peripheral blood samples of patients with advanced breast carcinoma using RT-PCR amplification of CK7 and MUC1. T Felton GC Harris SE Pinder DR Snead GI Carter JA Bell A Haines J Kollias JF Robertson CW Elston IO Ellis, Breast 2004 13 35 41 10.1016/S0960-9776(03)00126-7 14759714
20. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. PJ Bostick S Chatterjee DD Chi KT Huynh AE Giuliano R Cote DS Hoon, J Clin Oncol 1998 16 2632 2640 9704713 (Pubitemid 28363026)
21. The detection of circulating breast cancer cells in blood. AM Gilbey D Burnett RE Coleman I Holen, J Clin Pathol 2004 57 903 911 15333648 10.1136/jcp.2003.013755
22. A real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) to detect breast carcinoma cells in peripheral blood. J Aerts W Wynendaele R Paridaens MR Christiaens W van den Bogaert AT van Oosterom F Vandekerckhove, Ann Oncol 2001 12 39 46 10.1023/A:1008317512253 11249047
23. Real-time quantitative RT-PCR detection of disseminated endometrial tumor cells in peripheral blood and lymph nodes using the LightCycler System. XQ Ji H Sato H Tanaka Y Konishi T Fujimoto O Takahashi T Tanaka, Gynecol Oncol 2006 100 355 360 10.1016/j.ygyno.2005.08.041 16203027
24. Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes' stage, serum carcinoembryonic antigen level and tumor progression. IH Wong W Yeo AT Chan PJ Johnson, Cancer Lett 2001 162 65 73 10.1016/S0304-3835(00)00630-3 11121864
25. Immunomagnetic enrichment and detection of micrometastases in colorectal cancer: correlation with established clinical parameters. MR Weihrauch E Skibowski TC Koslowsky W Voiss D Re F Kuhn-Regnier C Bannwarth M Siedek V Diehl H Bohlen, J Clin Oncol 2002 20 4338 4343 10.1200/JCO.2002.02.152 12409333
26. Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer. N Xenidis I Vlachonikolis D Mavroudis M Perraki A Stathopoulou N Malamos C Kouroussis S Kakolyris S Apostolaki N Vardakis E Lianidou V Georgoulias, Ann Oncol 2003 14 849 855 10.1093/annonc/mdg259 12796021
27. Circulating breast cancer cells are frequently apoptotic. G Mehes A Witt E Kubista PF Ambros, Am J Pathol 2001 159 17 20 11438448 (Pubitemid 33704186)
28. Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro. R Jung W Kruger S Hosch M Holweg N Kroger K Gutensohn C Wagener M Neumaier AR Zander, Br J Cancer 1998 78 1194 1198 9820179 (Pubitemid 28479150)